RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01743326|
Recruitment Status : Unknown
Verified January 2015 by Maastricht University Medical Center.
Recruitment status was: Recruiting
First Posted : December 6, 2012
Last Update Posted : January 16, 2015
Rationale: the facet joints are an important pain generator in chronic neck pain. The beneficial effect of radio frequency treatment (RFD) of the cervical facet joints has been described in a Randomized Clinical Trial (RCT) in patients with Whiplash Associated Disorders. In patients with degenerative neck complaints a positive effect has been described in observational studies. Given this positive effect performing a RCT of RFD in this patient population is indicated.
Objective: to evaluate the effect of Radio Frequency treatment in patients with chronic degenerative neck pain.
Study design: prospective, randomized, double blinded clinical trial. Study population: patients older than 25 years, referred to the University Pain Center of Maastricht and the Pain Center of Amphia hospital Breda, with chronic axial neck pain.
Intervention: patients with at least 3 months of neck pain without radiation to the arm (only radiation beyond the shoulder) will be randomized in 2 groups. The first group (RFD + local anesthesia-group=intervention group) will receive RF treatment adjacent to the medial branch innervating the cervical facet joints after the application of bupivacaine 0.5 ml (0.25%). The second group (local anesthesia-group=control group) will only receive the application of 0.5 ml bupivacaine (0.25%) adjacent to the medial branch. The only difference between the two groups is the RF-denervation of the medial branches.
Main study parameters/endpoints: the primary research question is to evaluate the extent of pain reduction induced by RF treatment (RFD + local anesthesia-group=intervention group) compared with the local anesthesia-group(control group.
Following evaluation tools are used : Numeric Rating Scale (NRS), Patient global Impression of Change on a 7 point Likert Scale (PGIC), consumption of pain medication (MQS), Patient Specific Functional Scale, Quality of life scale (RAND 36), Hospital Anxiety and Depression scale (HADS), and Neck Disability Index (NDI, Dutch version).
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients in the RFD + Local Anesthesia-group and Local Anesthesia-group will undergo a physical examination before and 6 weeks after the intervention, by an independent third party, this will be repeated at 3 and 6 months if abnormalities are observed. At each of these time points the patients will receive questionnaires to fill out. A puncture of a blood vessel is possible, diagnosed by injection of contrast, for which repositioning of the needle is needed. Should accidental intravascular injection of local anesthetic occur, the dose used is low and reports show that intravascular injection of bupivacaine 2,5 mg does not pose clinical problems. The dura can be punctured; as a consequence contrast will flow in the cerebrospinal fluid. The procedure will be stopped and repeated after a few days. In theory a lesion of the nerve root is possible, but the needles are designed to avoid this, this complication has not been seen since more than 10 years. Up till now, a transient pain is occasionally described after the RF treatment. No hypesthesia or motor complications were reported. Since the risks of RF treatment are reported low and more related to needle placement there is no difference in risk and burden between the two treatment groups.
|Condition or disease||Intervention/treatment|
|Facet Joint Arthritis Pain Radiofrequency Denervation||Procedure: Radio Frequency Denervation Procedure: Local Anesthesia|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||84 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Percutaneous Radiofrequency Denervation of the Cervical Facet Joints Compared With Cervical Medial Branch Block of the Facet Joints for Patients With Chronic Degenerative Neck Pain : A Prospective Randomized Clinical Study|
|Study Start Date :||November 2012|
|Estimated Primary Completion Date :||June 2015|
|Estimated Study Completion Date :||June 2015|
Radio Frequency Denervation
|Procedure: Radio Frequency Denervation Procedure: Local Anesthesia|
Active Comparator: Local Anesthesia-group
|Procedure: Local Anesthesia|
- Mean pain intensity measured on a 11-point Numeric Rating Scale (NRS). [ Time Frame: Baseline, 6 months ]
- Patient Global Impression of Change according to a 7-point Likert scale (PGIC). [ Time Frame: Baseline, 6 months ]
- Changes in use of pain medication according to the Medication Quantification Scale (MQS). [ Time Frame: Baseline, 6 months ]
- Changes in the Neck Disability Index scale (NDI). [ Time Frame: Baseline, 6 months ]
- Changes in quality of life and differences between groups by means of RAND 36. [ Time Frame: Baseline, 6 months ]
- Improvement in functionality measured by the Patient Specific Functional Scale. [ Time Frame: Baseline, 6 months ]
- Change in physical/neurological examination parameters. [ Time Frame: Baseline, 6 months ]
- Change in employment status. [ Time Frame: Baseline, 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01743326
|Contact: Maarten van Eerd, MD||+31 43 firstname.lastname@example.org|
|Contact: Nelleke de Meij, MSc||+31 43 email@example.com|
|Maastricht University Medical Center||Recruiting|
|Maastricht, Limburg, Netherlands|
|Contact: Maarten van Eerd, MD +31 43 3875606 firstname.lastname@example.org|
|Contact: Nelleke de Meij, MSc +31 43 3872335 email@example.com|
|Principal Investigator: Maarten v Kleef, Prf. MD|
|Principal Investigator:||Maarten van Kleef, Prf. MD||Maastricht University Medical Centre|